EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Diversity of Pediatric Acute Myeloid Leukemia Genetic Drivers Correlates With Clinical Outcome and Expression of Stemness‐Related Genes

Quenton Rashawn Bubb iD, Elena Sotillo, Rebecca M Richards, Crystal L Mackall, Tanja A Gruber, Agnieszka Czechowicz

Cancer Medicine · 2025

DOI: 10.1002/cam4.71325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Quenton Rashawn Bubb und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Biology and Regenerative Medicine Graduate Program, Medical Scientist Training Program, Stanford University School of Medicine, Stanford, C…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Transcriptome, Biomarkers, Tumor, Neoplastic Stem Cells. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Society of Hematology, Parker Institute for Cancer Immunotherapy, Paul and Daisy Soros Fellowships for New Americans.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric acute myeloid leukemia (pAML) is comprised of a diverse set of oncogenic drivers (ODs) that have been risk‐stratified to inform prognosis and therapeutic decision‐making. Despite proteomic, transcriptomic, genetic, and epigenetic characterization of the pAML landscape, questions still remain about why certain ODs have poorer prognoses than others.

Methods

We analyze a large pAML bulk‐RNA dataset ( n = 435) and organize ODs along an axis of transcriptomic diversity by calculating the Simpson Diversity Index (SDI) of individual ODs.

Results

When comparing patients with low diversity ODs to patients with high diversity ODs, we observe poorer overall survival (HR = 1.877, 95% CI: 1.377–2.558, p = 0.0002) among patients harboring high diversity ODs in addition to an enrichment of stemness‐related genes. We observe poorer survival of patients with high diversity ODs even when comparing patients with similar transcriptomic profiles (HR = 3.443, 95% CI: 1.817–6.525, p = 0.0028).

Conclusion

We identify a link between transcriptomic diversity, expression of stemness‐related genes, and clinical outcome. Higher transcriptomic heterogeneity exhibited by high diversity ODs warrants further attention when identifying patients who can benefit from novel or high‐intensity therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTranscriptomeBiomarkers, TumorNeoplastic Stem CellsHumansChildPrognosisMaleFemaleGene Expression ProfilingAdolescentGene Expression Regulation, LeukemicChild, PreschoolInfant

Stichwörter der Autor:innen

pediatric AMLtranscriptomic diversitytranscriptomics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Stem Cell Biology and Regenerative Medicine Graduate Program, Medical Scientist Training Program, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California, USA.
  • Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Division of Blood and Stem Cell Transplantation and Cell Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Quenton Rashawn Bubb

Förderung

  • American Society of Hematology
  • Parker Institute for Cancer Immunotherapy
  • Paul and Daisy Soros Fellowships for New Americans
  • St. Baldrick's Foundation
  • Virginia and D.K. Ludwig Fund for Cancer Research
  • CURE Childhood Cancer Award

Zitieren

APA

Bubb, Q. R., Sotillo, E., Richards, R. M., Mackall, C. L., Gruber, T. A., & Czechowicz, A. (2025). Transcriptomic Diversity of Pediatric Acute Myeloid Leukemia Genetic Drivers Correlates With Clinical Outcome and Expression of Stemness‐Related Genes. Cancer Medicine. https://doi.org/10.1002/cam4.71325

Vancouver

Bubb QR, Sotillo E, Richards RM, Mackall CL, Gruber TA, Czechowicz A. Transcriptomic Diversity of Pediatric Acute Myeloid Leukemia Genetic Drivers Correlates With Clinical Outcome and Expression of Stemness‐Related Genes. Cancer Medicine. 2025. doi:10.1002/cam4.71325

BibTeX
@article{Bubb2025,
  author = {Bubb, Quenton Rashawn and Sotillo, Elena and Richards, Rebecca M and Mackall, Crystal L and Gruber, Tanja A and Czechowicz, Agnieszka},
  title = {Transcriptomic Diversity of Pediatric Acute Myeloid Leukemia Genetic Drivers Correlates With Clinical Outcome and Expression of Stemness‐Related Genes},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71325}
}
Kostenlos starten →